85 related articles for article (PubMed ID: 8314342)
1. p53 protein over-expression and p53 gene abnormalities in HIV-1-related non-Hodgkin's lymphomas.
De Re V; Carbone A; De Vita S; Gloghini A; Maestro R; Gasparotto D; Vukosavljevic T; Boiocchi M
Int J Cancer; 1994 Mar; 56(5):662-7. PubMed ID: 8314342
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the gene mutation of p53 and the protein expression of p53 and Ki-67 in non-Hodgkin's lymphomas.
Kuze T; Nakamura N; Hashimoto Y; Hojo H; Abe M; Wakasa H
Pathol Int; 1996 Feb; 46(2):130-6. PubMed ID: 10846560
[TBL] [Abstract][Full Text] [Related]
3. High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients.
Boiocchi M; De Re V; Gloghini A; Vaccher E; Dolcetti R; Marzotto A; Bertola G; Carbone A
Int J Cancer; 1993 Apr; 54(1):53-9. PubMed ID: 8386709
[TBL] [Abstract][Full Text] [Related]
4. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
[TBL] [Abstract][Full Text] [Related]
5. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M
Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655
[TBL] [Abstract][Full Text] [Related]
6. The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status.
Mansukhani MM; Osborne BM; Zhong J; Matsushima AY
Diagn Mol Pathol; 1997 Aug; 6(4):222-8. PubMed ID: 9360843
[TBL] [Abstract][Full Text] [Related]
7. Correlation between mutations in p53 gene and protein expression in human lymphomas.
Martinez-Delgado B; Robledo M; Arranz E; Infantes F; Echezarreta G; Marcos B; Sanz C; Rivas C; Benitez J
Am J Hematol; 1997 May; 55(1):1-8. PubMed ID: 9136910
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.
Kocialkowski S; Pezzella F; Morrison H; Jones M; Laha S; Harris AL; Mason DY; Gatter KC
Br J Haematol; 1995 Jan; 89(1):55-60. PubMed ID: 7833277
[TBL] [Abstract][Full Text] [Related]
9. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations.
Villuendas R; Piris MA; Algara P; Sánchez-Beato M; Sánchez-Verde L; Martinez JC; Orradre JL; García P; Lopez C; Martinez P
Blood; 1993 Nov; 82(10):3151-6. PubMed ID: 8219204
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
11. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.
Schlaifer D; Krajewski S; Galoin S; Rigal-Huguet F; Laurent G; Massip P; Pris J; Delsol G; Reed JC; Brousset P
Am J Pathol; 1996 Jul; 149(1):177-85. PubMed ID: 8686741
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas.
Kamata H; Mitani S; Fujiwara M; Aoki N; Okada S; Mori S
Clin Exp Med; 2007 Jun; 7(2):39-46. PubMed ID: 17609875
[TBL] [Abstract][Full Text] [Related]
14. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations and rearrangements in non-Hodgkin's lymphoma.
Chen PM; Chiou TJ; Hsieh RK; Fan FS; Chu CJ; Lin CZ; Chiang H; Yen CC; Wang WS; Liu JH
Cancer; 1999 Feb; 85(3):718-24. PubMed ID: 10091745
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related B-cell non-Hodgkin's lymphomas in direct blood-stream HIV-infected patients: pathogenesis and differentiation features.
Boiocchi M; Carbone A; De Re V; Dolcetti R; Volpe R; Tirelli U
Int J Cancer; 1990 May; 45(5):883-8. PubMed ID: 2159439
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas.
Doglioni C; Pelosio P; Mombello A; Scarpa A; Chilosi M
Hematol Pathol; 1991; 5(2):67-73. PubMed ID: 1680118
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in lymphatic malignancies.
Soini Y; Pääkkö P; Alavaikko M; Vähäkangas K
J Clin Pathol; 1992 Nov; 45(11):1011-4. PubMed ID: 1452775
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas.
Carbone A; Gloghini A; Zanette I; Canal B; Volpe R
Am J Clin Pathol; 1993 Mar; 99(3):289-97. PubMed ID: 8383422
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
